| International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 298 | 2015 |
| Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies S Petta, M Maida, FS Macaluso, M Barbara, A Licata, A Craxì, C Cammà Gastroenterology 150 (1), 145-155. e4, 2016 | 275 | 2016 |
| The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease S Petta, M Maida, FS Macaluso, V Di Marco, C Cammà, D Cabibi, A Craxì Hepatology 62 (4), 1101-1110, 2015 | 237 | 2015 |
| Screening of colorectal cancer: present and future M Maida, FS Macaluso, G Ianiro, F Mangiola, E Sinagra, G Hold, C Maida, ... Expert review of anticancer therapy 17 (12), 1131-1146, 2017 | 172 | 2017 |
| Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between … BD Juran, GM Hirschfield, P Invernizzi, EJ Atkinson, Y Li, G Xie, R Kosoy, ... Human molecular genetics 21 (23), 5209-5221, 2012 | 171 | 2012 |
| Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection S Petta, C Cammà, VD Marco, FS Macaluso, M Maida, G Pizzolanti, ... Liver International 31 (4), 507-515, 2011 | 116 | 2011 |
| Genetic background in nonalcoholic fatty liver disease: a comprehensive review FS Macaluso, M Maida, S Petta World Journal of Gastroenterology: WJG 21 (39), 11088, 2015 | 114 | 2015 |
| Cost‐effectiveness of sofosbuvir‐based triple therapy for untreated patients with genotype 1 chronic hepatitis C S Petta, G Cabibbo, M Enea, FS Macaluso, A Plaia, R Bruno, A Gasbarrini, ... Hepatology 59 (5), 1692-1705, 2014 | 99 | 2014 |
| Herbal hepatotoxicity: a hidden epidemic A Licata, FS Macaluso, A Craxì Internal and emergency medicine 8, 13-22, 2013 | 85 | 2013 |
| Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C FS Macaluso, M Maida, C Cammà, G Cabibbo, D Cabibi, R Alduino, ... Journal of hepatology 61 (3), 523-529, 2014 | 84 | 2014 |
| Cardiovascular diseases and HCV infection: a simple association or more? S Petta, FS Macaluso, A Craxì Gut 63 (3), 369-375, 2014 | 81 | 2014 |
| Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study A Licata, M Maida, D Cabibi, G Butera, FS Macaluso, N Alessi, C Caruso, ... Digestive and Liver Disease 46 (12), 1116-1120, 2014 | 77 | 2014 |
| Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients S Petta, S Grimaudo, VD Marco, C Scazzone, FS Macaluso, C Cammà, ... Journal of viral hepatitis 20 (7), 486-493, 2013 | 72 | 2013 |
| Pathway-based analysis of primary biliary cirrhosis genome-wide association studies SP Kar, MF Seldin, W Chen, E Lu, GM Hirschfield, P Invernizzi, ... Genes & Immunity 14 (3), 179-186, 2013 | 63 | 2013 |
| Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients S Petta, G Marchesini, L Caracausi, FS Macaluso, C Cammà, S Ciminnisi, ... Journal of Hepatology 59 (6), 1169-1176, 2013 | 60 | 2013 |
| Psoriasis and inflammatory bowel disease M Cottone, C Sapienza, FS Macaluso, M Cannizzaro Digestive Diseases 37 (6), 451-457, 2019 | 59 | 2019 |
| Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study A Licata, M Maida, A Bonaccorso, FS Macaluso, M Cappello, A Craxì, ... World journal of hepatology 5 (12), 685, 2013 | 50 | 2013 |
| COVID-19 in patients with inflammatory bowel disease: a systematic review of clinical data FS Macaluso, A Orlando Digestive and Liver Disease 52 (11), 1222-1227, 2020 | 47 | 2020 |
| Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease A Orlando, R Orlando, F Ciccia, S Renna, A Rizzo, M Cottone, ... Annals of the rheumatic diseases 76 (9), e31-e31, 2017 | 47 | 2017 |
| Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases S Petta, FS Macaluso, MR Barcellona, C Cammà, D Cabibi, V Di Marco, ... PLoS One 7 (12), e51165, 2012 | 45 | 2012 |
Marcello MaidaGastroenterology and Endoscopy Unit, S.Elia-Raimondi Hospital, CaltanissettaEmail verificata su unipa.it
